IRVINE, Calif., June 18, 2025 — As research and diagnostic companies grapple with rising prices and persistent backorders from offshore suppliers, Zymo Research is stepping up to fill the void with dependable, U.S.-based solutions. With over 30 years of experience as a trusted OEM and development partner, Zymo delivers high-quality, customizable solutions in sample collection, nucleic acid preservation and purification, reagents, enzymes, NGS library prep, plastics, and complete workflow design, all from its California headquarters.
“For over three decades, Zymo Research has invested in building the domestic infrastructure needed to support cutting-edge innovation, in-house manufacturing, and efficient inventory management,” said Dr. Marc Van Eden, VP of Corporate Development at Zymo Research. “This enables us to provide fast, uninterrupted delivery to our clients across the U.S. We’re doing something unusual in today’s market — putting our customers first. We believe real people providing real solutions is what sets us apart. Customer service isn’t a department here at Zymo; it’s a core value.”
Zymo’s full-spectrum capabilities include:
- Private Label and OEM Supply
- Collaboration & Co-development
- Custom Formulation and Filling
- Bulk Raw Material Provision
- Product Design, Labeling, and Packaging
- Plastic Design and Injection Molding
- Custom Bioinformatics and Reporting
In addition to offering end-to-end workflow support, Zymo also maintains state-of-the-art infrastructure for recombinant protein production, delivering workhorse enzymes like Proteinase K, DNase I, and RNase A for research and clinical applications.
As global supply chains continue to shift, Zymo remains a stable, science-first partner committed to flexibility, reliability, and collaborative innovation.
Made in California. Delivered worldwide. Trusted by scientists.
